<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30652746</article-id><article-id pub-id-type="pmc">6326450</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0093</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Should Sinus of Valsalva be Replaced in Patients with Dilated
Ascending Aorta and Aortic Valve Diseases?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Salihi</surname><given-names>Salih</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Cant&#x000fc;rk</surname><given-names>Emir</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>K&#x000f6;ksal</surname><given-names>Cengiz</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Alp</surname><given-names>H&#x00131;z&#x00131;r Mete</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Cardiovascular Surgery, Okan University, Medicine
Faculty Hospital, Istanbul, Turkey. </aff><aff id="aff2">
<label>2</label> Department of Cardiovascular Surgery, Bezmialem Vak&#x00131;f
University, Medical Faculty, Istanbul, Turkey. </aff><author-notes><corresp id="c1">Correspondence Address: Cengiz K&#x000f6;ksal, Bezmialem
Vak&#x00131;f University, Dragos Hospital, Sahil Yolu Cad. No:16, 34844 -
Maltepe, Istanbul, Turkey, E-mail: <email>cekoksal@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2018</year></pub-date><volume>33</volume><issue>6</issue><fpage>573</fpage><lpage>578</lpage><history><date date-type="received"><day>26</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>The aim of this study is to investigate the change in the dimension of sinus
of Valsalva in patients who underwent supracoronary ascending aorta
replacement with aortic valve replacement.</p></sec><sec><title>Methods</title><p>A total of 81 patients who underwent supracoronary ascending aorta
replacement with aortic valve replacement were included. Ten of 81 patients
died during the follow-up. The patients were divided into three groups
according to the aortic valve diseases. Group I (n=17) included patients
with bicuspid valves, group II (n=30) included patients with stenotic
degenerative valves, and patients with aortic regurgitation constituted
group III (n=24). In preoperative and follow-up periods, the sinus of
Valsalva diameter of the patients was evaluated by echocardiographic
examination. The mean age was 54.1&#x000b1;15.1 years. Twenty-eight (34.6%)
patients were female and 12 (14.8%) patients were in New York Heart
Association functional class III.</p></sec><sec><title>Results</title><p>There was no early mortality. Late mortality was developed in 10 (12.4%)
patients, 8 (9.9%) due to non-cardiac reasons. Late follow-up was obtained
in 71 patients with a mean of 60&#x000b1;30.1 months postoperatively. During
follow-up, the increase in the diameter of the sinus of Valsalva was
significant in Group I (<italic>P</italic>&#x0003c;0.01), while in Group II and
III it was insignificant (<italic>P</italic>&#x0003e;0.05).</p></sec><sec><title>Conclusion</title><p>To avoid the risks associated with sinus of Valsalva dilatation, it is
reasonable to replace the sinus of Valsalva in the setting of aortic valve
replacement and ascending aorta replacement for bicuspid aortic valve with a
dilated ascending aorta and relatively normal sinuses of Valsalva in young
patients.</p></sec></abstract><kwd-group><kwd>Aortic Aneurysm</kwd><kwd>Aortic Aneurysm, Thoracic/Surgery</kwd><kwd>Aorta/Surgery</kwd><kwd>Aortic Valve/Abnormalities</kwd><kwd>Bicuspid Aortic Valve</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="20%" span="1"/><col width="80%" span="1"/></colgroup><thead><tr style="background-color:#eaeaea"><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>AAA</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Ascending aortic aneurysms</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>AAR</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Ascending aorta replacement</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>AVR</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Aortic valve replacement</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>BAV</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Bicuspid aortic valve</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>NCSS</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Number Cruncher Statistical System</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>NYHA</bold></td><td align="left" rowspan="1" colspan="1"><bold>= New York Heart Association</bold></td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The prognosis of aortic valve diseases with ascending aortic aneurysms (AAA) varies
according to the underlying etiology. The surgical strategy often depends on the
aortic valve disease. Procedures include supracoronary ascending aorta replacement
(AAR) with aortic valve replacement (AVR) and composite aortic valve graft
replacement (Bentall-De Bono). It is often believed that the aortic aneurysm seen
along with degenerative aortic stenosis is due to post-stenotic
dilatation<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Valve intervention is necessary when aortic
regurgitation is seen along with AAA. In the past, supracoronary AAR with AVR or
composite aortic valve graft replacement was commonly used for these patients. In
recent years, valve-sparing aortic root replacement surgery is preferred in aortic
root dilatation with normofunctional valves. Performing AAR+AVR in patients with
bicuspid aortic valve (BAV) do not completely remove the underlying pathology, since
the defect remains in the tunica media of the aorta. The aim of this study is to
investigate the change in the dimension of sinus of Valsalva in patients who
underwent supracoronary AAR together with AVR.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Design and Patient's Population</title><p>This is a retrospective study of 81 patients who underwent AAR+AVR for AAA and
aortic valve diseases. After receiving approval of the Institutional Ethics
Committee of our hospital, we retrospectively reviewed the medical records of
patients who underwent AAR+AVR at Kartal Ko&#x0015f;uyolu Yuksek Ihtisas
Education and Research Hospital. Patients who underwent additional procedures
were excluded. All preoperative, intraoperative and postoperative data were
collected. The status of the patients was determined through telephone
interviews and the examination of patients' cards. During follow-up, 10 (12.4%)
of 81 patients died. The causes of late death in these patients were myocardial
infarction, cerebrovascular accident and colorectal cancer.</p><p>The patients were divided into three groups according to the aortic valve
diseases. Group I (n=17) included patients with bicuspid valves, group II (n=30)
was made up of patients with stenotic degenerative valves, and patients with
aortic valve regurgitation constituted group III (n=24). The mean follow-up
periods were 46.59&#x000b1;12.64 months, 69.20&#x000b1;38.42 months and
58.50&#x000b1;23.29 months for groups I, II and III, respectively. Preoperative
findings of the patients are summarized in <xref rid="t1" ref-type="table">Table
1</xref>. Of the 81 patients, 53 (65.4 %) were male and the mean age was
52.84&#x000b1;15.53 years. Twelve (14.8%) patients were in New York Heart
Association (NYHA) functional class III and there were two patients with poor
left ventricular function.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic characteristics.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Preoperative variables</th><th align="center" rowspan="1" colspan="1">(n=81)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">54.1&#x000b1;15.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (female), n (%)</td><td align="center" rowspan="1" colspan="1">28 (34.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">165.3&#x000b1;9.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">72&#x000b1;13.5</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA III, n (%)</td><td align="center" rowspan="1" colspan="1">12 (14.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative AF, n (%)</td><td align="center" rowspan="1" colspan="1">9 (11.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">52 (64.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus, n (%)</td><td align="center" rowspan="1" colspan="1">9 (11.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking, n (%)</td><td align="center" rowspan="1" colspan="1">35 (43.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">LV function (EF/%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Good, n (%)</td><td align="center" rowspan="1" colspan="1">55 (67.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Moderate, n (%)</td><td align="center" rowspan="1" colspan="1">24 (29.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; Poor, n (%)</td><td align="center" rowspan="1" colspan="1">2 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">LVESD (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">39&#x000b1;11</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEDD (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">56&#x000b1;10</td></tr><tr><td align="left" rowspan="1" colspan="1">AAD (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">53&#x000b1;8</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>Data are presented as mean value&#x000b1;standard deviation, median
value, or number of patients. AAD=ascending aorta diameter;
AF=atrial fibrillation; LV=left ventricle; EF=ejection fraction;
LVEDD=left ventricular end-diastolic diameter; LVESD=left
ventricular end-systolic diameter; NYHA=New York Heart
Association</p></fn></table-wrap-foot></table-wrap><p>In the follow-up period, the change in the sinus of Valsalva diameter of the
patients was evaluated with echocardiographic examination. Preoperative
echocardiographic data, such as ejection fraction, left ventricular
end-systolic, end-diastolic diameters and diameters of ascending aorta and sinus
of Valsalva were collected and evaluated (<xref rid="t1" ref-type="table">Table
1</xref>).</p></sec><sec><title>Statistical Analysis</title><p>Number Cruncher Statistical System (NCSS) 2007&#x00026;PASS 2008 Statistical Software
(Utah, USA) was used for statistical analysis. In the evaluation of data,
descriptive statistical methods (mean, standard deviation, frequency) were used.
Data were analyzed by one-way ANOVA, paired samples T-test, and T-test.
Chi-square and McNemar's test were used in the comparison of qualitative data. A
two-tailed probability (<italic>P</italic>) value of &#x0003c;0.05 was considered to
be statistically significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Operative data are shown in <xref rid="t2" ref-type="table">Table 2</xref>. The
aortic valve was replaced by a tissue valve in 4 (4.9%) patients, and a mechanical
valve in 77 (95.1%) patients. The mean size of the replaced valve was
23.50&#x000b1;1.6 mm. All patients received a Dacron graft with a mean size of
29.3&#x000b1;1.6 mm.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Intraoperative parameters.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="35%" span="1"/><col width="33%" span="1"/><col width="32%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">(n=81)</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">Artery cannulation, n (%)</td><td align="left" rowspan="1" colspan="1">Distal ascending aorta</td><td align="center" rowspan="1" colspan="1">32 (39.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Femoral artery</td><td align="center" rowspan="1" colspan="1">33 (40.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Axillary artery</td><td align="center" rowspan="1" colspan="1">15 (18.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Innominate artery</td><td align="center" rowspan="1" colspan="1">1 (1.3%)</td></tr><tr><td align="left" rowspan="2" colspan="1">Vein cannulation, n (%)</td><td align="left" rowspan="1" colspan="1">Right atrium</td><td align="center" rowspan="1" colspan="1">79 (97.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Femoral vein</td><td align="center" rowspan="1" colspan="1">2 (2.5%)</td></tr><tr><td align="left" rowspan="3" colspan="1">Cardioplegia, n (%)</td><td align="left" rowspan="1" colspan="1">Antegrade</td><td align="center" rowspan="1" colspan="1">6 (7.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Retrograde</td><td align="center" rowspan="1" colspan="1">44 (54.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Antegrade and retrograde</td><td align="center" rowspan="1" colspan="1">31 (38.3%)</td></tr><tr><td align="left" rowspan="2" colspan="1">Prosthetic valve, n (%)</td><td align="left" rowspan="1" colspan="1">Mechanical</td><td align="center" rowspan="1" colspan="1">77 (95.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Biological</td><td align="center" rowspan="1" colspan="1">4 (4.9%)</td></tr><tr><td align="left" rowspan="3" colspan="1">Hypothermia, n (%)</td><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">20 (24.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">55 (67.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Deep</td><td align="center" rowspan="1" colspan="1">6 (7.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">TCA, n (%)</td><td align="left" rowspan="1" colspan="1">Used</td><td align="center" rowspan="1" colspan="1">16 (19.7%)</td></tr><tr><td align="left" rowspan="3" colspan="1">Cerebral perfusion, n (%)</td><td align="left" rowspan="1" colspan="1">Antegrade</td><td align="center" rowspan="1" colspan="1">10 (12.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Retrograde</td><td align="center" rowspan="1" colspan="1">6 (7.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nil</td><td align="center" rowspan="1" colspan="1">65 (80.3%)</td></tr><tr><td align="left" colspan="2" rowspan="1">APV (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">23.5&#x000b1;1.6</td></tr><tr><td align="left" colspan="2" rowspan="1">Aortic graft size (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">29.3&#x000b1;1.6</td></tr><tr><td align="left" colspan="2" rowspan="1">TPT (min/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">145.9&#x000b1;46.7</td></tr><tr><td align="left" colspan="2" rowspan="1">ACC (min/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">99&#x000b1;36</td></tr><tr><td align="left" colspan="2" rowspan="1">ICU stay (days)</td><td align="center" rowspan="1" colspan="1">3.8&#x000b1;1.8</td></tr><tr><td align="left" colspan="2" rowspan="1">Hospital stay (days)</td><td align="center" rowspan="1" colspan="1">10.3&#x000b1;4.2</td></tr></tbody></table><table-wrap-foot><fn id="TFN02"><p>ACC=aortic cross-clamping time; APV=aortic prosthetic valve;
ICU=intensive care unit; TCA=total circulatory arrest; TPT=total
perfusion time</p></fn></table-wrap-foot></table-wrap><sec><title>Follow-Up</title><p>Early complications after AAR+AVR are presented in <xref rid="t3" ref-type="table">Table 3</xref>. There was no early mortality (&#x0003c;30 days). The
mean intensive care unit and hospital length of stay were 3.8&#x000b1;1.8 and
10.3&#x000b1;4.2 days, respectively. New-onset atrial fibrillation developed in
16 (19.7%) patients and was medically resolved in all. Inotropic support over 24
hours was needed in 10 cases, and cerebrovascular accident was treated in 4
patients.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Early and late morbidity and mortality. </p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="70%" span="1"/><col width="30%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">n (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Early (&#x0003c;30 days)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Mortality</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;New-onset atrial fibrillation</td><td align="center" rowspan="1" colspan="1">16 (19.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Reoperation for bleeding</td><td align="center" rowspan="1" colspan="1">2 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Pleural effusion requiring drainage</td><td align="center" rowspan="1" colspan="1">8 (9.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Inotropic support &#x0003e;24 hours</td><td align="center" rowspan="1" colspan="1">10 (12.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Acute renal failure</td><td align="center" rowspan="1" colspan="1">3 (3.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">4 (4.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Permanent pacemaker implantation</td><td align="center" rowspan="1" colspan="1">1 (1.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Pulmonary complications</td><td align="center" rowspan="1" colspan="1">5 (6.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Superficial wound infection</td><td align="center" rowspan="1" colspan="1">2 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Late</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Mortality</td><td align="center" rowspan="1" colspan="1">10 (12.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cardiac</td><td align="center" rowspan="1" colspan="1">2 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Non-cardiac</td><td align="center" rowspan="1" colspan="1">8 (9.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Reoperation</td><td align="center" rowspan="1" colspan="1">1 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Endocarditis</td><td align="center" rowspan="1" colspan="1">1 (2.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Thromboembolism</td><td align="center" rowspan="1" colspan="1">2 (4.3%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN03"><p>Data are presented as mean&#x000b1;SD or as number and percentage.</p></fn></table-wrap-foot></table-wrap><p>Late follow-up was obtained in 71 patients with a mean of 60&#x000b1;30.1 months
postoperatively. Mortality developed in 10 (12.4%) patients, 8 (9.9%) due to
non-cardiac reasons. Only one (2%) patient needed reoperation because of
infective endocarditis.</p><p>Postoperative echocardiographic parameters, such as the interventricular septum,
the maximum and the mean transvalvular gradient across the aortic valve, and
sinotubular junction and sinus of Valsalva diameters for each group are
presented in <xref rid="t4" ref-type="table">Table 4</xref>.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Postoperative echocardiographic parameters.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Echocardiographic parameters</th><th align="center" rowspan="1" colspan="1">Group I<break/>(n=17)</th><th align="center" rowspan="1" colspan="1">Group II<break/>(n=30)</th><th align="center" rowspan="1" colspan="1">Group III<break/>(n=24)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IVS, (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">11.70&#x000b1;1.72</td><td align="center" rowspan="1" colspan="1">11.83&#x000b1;2.32</td><td align="center" rowspan="1" colspan="1">10.79&#x000b1;1.02</td><td align="center" rowspan="1" colspan="1">0.100</td></tr><tr><td align="left" rowspan="1" colspan="1">Max grad, (mmHg/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">26.23&#x000b1;11.61</td><td align="center" rowspan="1" colspan="1">30.03&#x000b1;14.40</td><td align="center" rowspan="1" colspan="1">22.41&#x000b1;8.03</td><td align="center" rowspan="1" colspan="1">0.072</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean grad, (mmHg/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">14.65&#x000b1;8.06</td><td align="center" rowspan="1" colspan="1">16.30&#x000b1;8.56</td><td align="center" rowspan="1" colspan="1">12.12&#x000b1;5.05</td><td align="center" rowspan="1" colspan="1">0.129</td></tr><tr><td align="left" rowspan="1" colspan="1">Sinus of Valsalva diameter (mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">37.76&#x000b1;6.36</td><td align="center" rowspan="1" colspan="1">36.10&#x000b1;5.12</td><td align="center" rowspan="1" colspan="1">37.50&#x000b1;4.86</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">Sinotubular junction diameter
(mm/mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">32.53&#x000b1;5.58</td><td align="center" rowspan="1" colspan="1">31.03&#x000b1;7.17</td><td align="center" rowspan="1" colspan="1">32.87&#x000b1;4.32</td><td align="center" rowspan="1" colspan="1">0.491</td></tr></tbody></table><table-wrap-foot><fn id="TFN04"><p>One-way ANOVA test.</p></fn><fn id="TFN05"><p>IVS=interventricular septum; Max grad=maximum gradient; Mean
grad=mean gradient</p></fn></table-wrap-foot></table-wrap><p>There was no significant difference among the groups in the postoperative sinus
of Valsalva diameter (<italic>P</italic>&#x0003e;0.05) (<xref rid="t4" ref-type="table">Table 4</xref>). The increase in postoperative sinus of Valsalva
diameter compared to preoperative size in Group I was statistically significant
(<italic>P</italic>&#x0003c;0.01). There was no significant change in
postoperative sinus of Valsalva diameter compared to preoperative size in Groups
II and III (<italic>P</italic>&#x0003e;0.05) (<xref rid="t5" ref-type="table">Table
5</xref>). The postoperative increase in the sinus of Valsalva diameter,
compared to preoperative size in the Group I, was significantly higher when
compared to Group II and Group III (<italic>P</italic>&#x0003c;0.01).</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Changes in sinus of Valsalva diameters in different groups. </p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="32%" span="1"/><col width="17%" span="1"/><col width="17%" span="1"/><col width="17%" span="1"/><col width="17%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Sinus of Valsalva diameter</th><th align="center" rowspan="1" colspan="1">Group I<break/>(n=17)</th><th align="center" rowspan="1" colspan="1">Group II<break/>(n=30)</th><th align="center" rowspan="1" colspan="1">Group III<break/>(n=24)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="TFN06"><sup>+</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Preoperative</td><td align="center" rowspan="1" colspan="1">32.76&#x000b1;2.13</td><td align="center" rowspan="1" colspan="1">35.80&#x000b1;5.26</td><td align="center" rowspan="1" colspan="1">36.96&#x000b1;4.93</td><td align="center" rowspan="1" colspan="1">0.018<xref ref-type="table-fn" rid="TFN08">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative</td><td align="center" rowspan="1" colspan="1">37.76&#x000b1;6.36</td><td align="center" rowspan="1" colspan="1">36.10&#x000b1;5.12</td><td align="center" rowspan="1" colspan="1">37.50&#x000b1;4.86</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="TFN07"><sup>++</sup></xref></td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="TFN09">**</xref></td><td align="center" rowspan="1" colspan="1">0.071</td><td align="center" rowspan="1" colspan="1">0.085</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN06"><label>+</label><p>One-way ANOVA test;</p></fn><fn id="TFN07"><label>++</label><p>Paired sample t-test;</p></fn><fn id="TFN08"><label>*</label><p><italic>P</italic>&#x0003c;0.05;</p></fn><fn id="TFN09"><label>**</label><p><italic>P</italic>&#x0003c;0.01.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>There are a number of surgical strategies for patients with AAA and concomitant
aortic valve diseases. When aortic root aneurysm is present, Bentall-De Bono surgery
is preferred, while AVR and supracoronary AAR is used in patients with AAA and
aortic valve pathologies without annular or sinus dilatation<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The operative outcomes
of supracoronary AAR with AVR are excellent and there is no additional risk in
elective and non-high-risk patients<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The aetiology of valvular disease,
intraoperative shape and ascending aortic wall thickness and the patient's condition
are important factors for surgical decision in BAV<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>AAA seen in aortic stenosis of calcific degeneration is usually post-stenotic
dilatation. It is progressive and its rate of increase is reported to be &#x0003e;3
mm/year<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. If aortic valve and ascending aorta were replaced
in these patients, the underlying pathology would be cured. In our study, 30
patients had aortic stenosis caused by calcific degeneration. Regarding the sinus of
Valsalva diameter, the postoperative diameter, compared to the preoperative size,
did not change significantly (<italic>P</italic>&#x0003e;0.05). In AAA with aortic valve
insufficiency, the sinus of Valsalva diameter is also enlarged. With progression of
AAA, dilatation of the sinotubular junction, displacement of commissures, distortion
or dilatation of one or more sinus of Valsalva, annuloaortic ectasia alone or in
combination can cause aortic regurgitation. In our study, 24 patients underwent
AAR+AVR due to aortic regurgitation and AAA. The postoperative sinus of Valsalva
diameter, compared with preoperative size, was not significantly different
(<italic>P</italic>&#x0003e;0.05). Although sinus of Valsalva was dilated
preoperatively in some patients, composite valve-graft replacement or valve-sparing
aortic root replacement was not performed. These operations may have been avoided
because of the patients' advanced age.</p><p>BAV is not just a valvular disease, but a component of a wider pathology also
including the ascending aorta<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Although tunica media and normal aortic valve
in BAV is the same, the gap between elastic lamella is greater. Patients with BAV
have thinner elastic lamellae of the aortic medium than patients with tricuspid
aortic valve<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Fibrillin-1 is a glycoprotein needed for structural
continuity of aortic wall and valves. Fibrillin-1 deficiency is more common in BAV
compared with that seen in tricuspid aortic valves<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Higher activity of
proteolytic enzymes known as matrix metalloproteins was seen in aortic aneurysms
associated with BAV when compared to aneurysms of patients with tricuspid
valves<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. High tension and shear stress play an important role in
the pathogenesis of ascending aortic aneurysm with BAV. Tensile stress is the force
perpendicular to the aortic wall, and increases with aortic diameter according to
the law of Laplace. On the other hand, shear stress is a product of blood viscosity
and velocity and is a force parallel to the aortic wall causing friction to the
endothelial surface<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Current guidelines suggest the replacement of the
ascending aorta in the presence of a diameter of 50 mm or more, if associated with
BAV disease with additional risk factors or coarctation<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>In our study, AAR+AVR was performed in 17 patients with BAV and AAA. Postoperative
sinus of Valsalva diameter, compared with the preoperative size, was significantly
increased in these patients (P&#x0003c;0.01). The follow-up period of these patients was
46.59&#x000b1;12.64 months.</p><p>The relationship between follow-up duration and sinus of Valsalva diameter was not
statistically significant. It could be due to a small numbers of patients and
shorter follow-up in some patients. An increase of 5&#x000b1;4.63 mm in sinus of
Valsalva diameter was noted in this short follow-up. Longer follow-up duration in a
larger group of patients could have revealed a significant increase in sinus of
Valsalva diameter because the disease is progressive. Although the evolution of the
ascending aorta with BAV is well documented in many studies<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>, the risk of
progressive sinus of Valsalva dilatation is less clear. Vendramin et
al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> showed that no progressive sinus Valsalva
dilatation is recorded in the long-term follow-up. Conversely, a significant
reduction of the mean aortic root diameter was observed in some patients.</p><p>According to Yasuda et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>, BAV replacement, either by stenosis or failure,
did not prevent the progressive dilation of the proximal aorta, which differs from
that observed in patients with tricuspid aortic valve.</p><p>Russo et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>, when following-up more than 100 patients
undergoing AVR, also reported a higher incidence of sudden death and aortic
dissection in a group of patients with BAV, a significantly larger increase in
aortic diameter in the same group, suggesting that prophylactic surgery for
replacement of the ascending aorta concomitant with valve replacement should be
performed, even in the presence of mild dilation of the ascending aorta.</p><p>Borger et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, in a clinical retrospective study assessing the
aortic complications in patients with BAV, concluded that patients with aortic
diameter exceeding 45 mm should undergo combined surgery, or that is, AVR and
replacement of the ascending aorta to avoid reinterventions due to vascular
complications, either aneurysms and dissections of the ascending aorta. In another
study, there were no late reoperations for aortic root dissection or rupture in 124
BAV patients who underwent AAR+AVR during a follow-up of 75.2
months<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>Study published by Etz et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> reported that in cases of surgery due to aortic
valve disease, associated with a diameter of the root or ascending aorta exceeding
4.0 cm and life expectancy greater than 10 years, the option was to replace both the
valve and the aorta.</p><p>Some studies have shown that sinus of Valsalva aneurysm developed in long-term
follow-up of patients who underwent AAR+AVR because of type A
dissection<sup>[<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. In our hospital, valve-sparing aortic root
replacement or composite valve-graft replacement was performed in patients with type
A dissection. That is the reason why we did not include these patients to our
study.</p><p>In a study by Yun et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>, 49 of the 255 patients who underwent AAR+AVR were
reoperated for aortic root pathologies. In a study by Hou&#x000eb;l et
al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>,
the rate of freedom from second operation for aortic root pathologies was
97.3&#x000b1;1.9% in composite valve-graft replacement and 68.3&#x000b1;9% in AAR+AVR.
It was stated that AAR+AVR was a risk factor for complications related to the aortic
root. When these two studies were compared to our study, the rate of complications
related to the aortic root was lower in our study. We included 71 patients and no
patient was reoperated for aortic root pathologies in the medium-term follow-up. We
assumed that this success was due to the choice of proper surgical technique and
exclusion of dissection.</p><sec><title>Limitations</title><p>The major limitation of this study is its retrospective nature, spanning 10 years
and involving a limited number of patients. A potential limitation of our study
is the short duration of follow-up in some patients.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In patients with ascending aortic aneurysm and concomitant aortic valve diseases, the
surgical technique should be selected according to the underlying disease. To avoid
the risks associated with sinus of Valsalva dilatation, it is reasonable to replace
the sinus of Valsalva in the setting of AVR and AAR for BAV with a dilated ascending
aorta and relatively normal sinuses of Valsalva in young patients.</p><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1"><bold>Authors&#x02019; roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">EC</td><td align="left" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">CK</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; agreement to be accountable for all aspects of the
work in ensuring that questions related to the accuracy or integrity
of any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">HMA</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Department of Cardiovascular Surgery, Okan
University, Medicine Faculty Hospital, Istanbul, Turkey.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilton</surname><given-names>E</given-names></name><name><surname>Jahangiri</surname><given-names>M</given-names></name></person-group><article-title>Post-stenotic aortic dilatation</article-title><source>J Cardiothoracic Surg</source><year>2006</year><volume>1</volume><fpage>7</fpage><lpage>7</lpage></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sioris</surname><given-names>T</given-names></name><name><surname>David</surname><given-names>TE</given-names></name><name><surname>Ivanov</surname><given-names>J</given-names></name><name><surname>Armstrong</surname><given-names>S</given-names></name><name><surname>Feindel</surname><given-names>CM</given-names></name></person-group><article-title>Clinical outcomes after separate and composite replacement of the
aortic valve and ascending aorta</article-title><source>J Thorac Cardiovasc Surg</source><year>2004</year><volume>128</volume><issue>2</issue><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15282463</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagl</surname><given-names>C</given-names></name><name><surname>Strauch</surname><given-names>JT</given-names></name><name><surname>Spielvogel</surname><given-names>D</given-names></name><name><surname>Galla</surname><given-names>JD</given-names></name><name><surname>Lansman</surname><given-names>SL</given-names></name><name><surname>Squitieri</surname><given-names>R</given-names></name><etal/></person-group><article-title>Is the Bentall procedure for ascending aorta or aortic valve
replacement the best approach for long-term event-free
survival</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>76</volume><issue>3</issue><fpage>698</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">12963181</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterss</surname><given-names>S</given-names></name><name><surname>Charilaou</surname><given-names>P</given-names></name><name><surname>Dumfarth</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Bhandari</surname><given-names>R</given-names></name><name><surname>Tranquilli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Aortic valve disease with ascending aortic aneurysm: Impact of
concomitant root-sparing (supracoronary) aortic replacement in nonsyndromic
patients</article-title><source>J Thorac Cardiovasc Surg</source><year>2016</year><volume>152</volume><issue>3</issue><fpage>791</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">27318616</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner</surname><given-names>H</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>De Bonis</surname><given-names>M</given-names></name><name><surname>Hamm</surname><given-names>C</given-names></name><name><surname>Holm</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>2017 ESC/EACTS Guidelines for the management of valvular heart
disease</article-title><source>Eur Heart J</source><year>2017</year><volume>38</volume><issue>36</issue><fpage>2739</fpage><lpage>2791</lpage><pub-id pub-id-type="pmid">28886619</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilgen</surname><given-names>F</given-names></name></person-group><article-title>Ascending aorta replacement in bicuspid aortic valve:
when?</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2011</year><volume>19</volume><issue>Suppl 2</issue><fpage>15</fpage><lpage>18</lpage></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Pasic</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>R</given-names></name><name><surname>Goetze</surname><given-names>N</given-names></name><name><surname>Bauer</surname><given-names>U</given-names></name><name><surname>Siniawski</surname><given-names>H</given-names></name><etal/></person-group><article-title>Morphometric analysis of aortic media in patients with bicuspid
and tricuspid aortic valve</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><issue>1</issue><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12118804</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedak</surname><given-names>PW</given-names></name><name><surname>Sa</surname><given-names>MP</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Nili</surname><given-names>N</given-names></name><name><surname>Kazemian</surname><given-names>P</given-names></name><name><surname>Butany</surname><given-names>J</given-names></name><etal/></person-group><article-title>Vascular matrix remodeling in patients with bicuspid aortic valve
malformations: implications for aortic dilatation</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>126</volume><issue>3</issue><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">14502156</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyum</surname><given-names>J</given-names></name><name><surname>Fellinger</surname><given-names>EK</given-names></name><name><surname>Schmoker</surname><given-names>JD</given-names></name><name><surname>Trombley</surname><given-names>L</given-names></name><name><surname>McPartland</surname><given-names>K</given-names></name><name><surname>Ittleman</surname><given-names>FP</given-names></name><etal/></person-group><article-title>Matrix metalloproteinase activity in thoracic aortic aneurysms
associated with bicuspid and tricuspid aortic valves</article-title><source>J Thorac Cardiovasc Surg</source><year>2004</year><volume>127</volume><issue>3</issue><fpage>686</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">15001896</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>CB</given-names></name><name><surname>Greason</surname><given-names>KL</given-names></name><name><surname>Suri</surname><given-names>RM</given-names></name><name><surname>Michelena</surname><given-names>HI</given-names></name><name><surname>Schaff</surname><given-names>HV</given-names></name><name><surname>Sundt 3rd</surname><given-names>TM</given-names></name></person-group><article-title>Fate of nonreplaced sinuses of Valsalva in bicuspid aortic valve
disease</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>142</volume><issue>2</issue><fpage>278</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">21036368</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardi</surname><given-names>P</given-names></name><name><surname>Pellegrino</surname><given-names>A</given-names></name><name><surname>Russo</surname><given-names>M</given-names></name><name><surname>Saitto</surname><given-names>G</given-names></name><name><surname>Bertoldo</surname><given-names>F</given-names></name><name><surname>Chiariello</surname><given-names>L</given-names></name></person-group><article-title>Midterm results of different surgical techniques to replace
dilated ascending aorta associated with bicuspid aortic valve
disease</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>96</volume><issue>5</issue><fpage>1648</fpage><lpage>1654</lpage><pub-id pub-id-type="pmid">23987905</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vendramin</surname><given-names>I</given-names></name><name><surname>Meneguzzi</surname><given-names>M</given-names></name><name><surname>Sponga</surname><given-names>S</given-names></name><name><surname>Deroma</surname><given-names>L</given-names></name><name><surname>Cimarosti</surname><given-names>R</given-names></name><name><surname>Lutman</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bicuspid aortic valve disease and ascending aortic aneurysm:
should an aortic root replacement be mandatory?</article-title><source>Eur J Cardiothorac Surg</source><year>2016</year><volume>49</volume><issue>1</issue><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">25750009</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>H</given-names></name><name><surname>Nakatani</surname><given-names>S</given-names></name><name><surname>Stugaard</surname><given-names>M</given-names></name><name><surname>Tsujita-Kuroda</surname><given-names>Y</given-names></name><name><surname>Bando</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Failure to prevent progressive dilation of ascending aorta by
aortic valve replacement in patients with bicuspid aortic valve: comparison
with tricuspid aortic valve</article-title><source>Circulation</source><year>2003</year><volume>108</volume><issue>Suppl 1</issue><fpage>II291</fpage><lpage>II294</lpage><pub-id pub-id-type="pmid">12970248</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>CF</given-names></name><name><surname>Mazzetti</surname><given-names>S</given-names></name><name><surname>Garatti</surname><given-names>A</given-names></name><name><surname>Ribera</surname><given-names>E</given-names></name><name><surname>Milazzo</surname><given-names>A</given-names></name><name><surname>Bruschi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Aortic complications after bicuspid aortic valve replacement:
long-term results</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><issue>5</issue><fpage>S1773</fpage><lpage>S1776</lpage><pub-id pub-id-type="pmid">12440663</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borger</surname><given-names>MA</given-names></name><name><surname>Preston</surname><given-names>M</given-names></name><name><surname>Ivanov</surname><given-names>J</given-names></name><name><surname>Fedak</surname><given-names>PW</given-names></name><name><surname>Davierwala</surname><given-names>P</given-names></name><name><surname>Armstrong</surname><given-names>S</given-names></name><etal/></person-group><article-title>Should the ascending aorta be replaced more frequently in
patients with bicuspid aortic valve disease</article-title><source>J Thorac Cardiovasc Surg</source><year>2004</year><volume>128</volume><issue>5</issue><fpage>677</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">15514594</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Should sinus of Valsalva be preserved in patients with bicuspid
aortic valve and aortic dilation?</article-title><source>J Thorac Dis</source><year>2017</year><volume>9</volume><issue>9</issue><fpage>3148</fpage><lpage>3153</lpage><pub-id pub-id-type="pmid">29221290</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etz</surname><given-names>CD</given-names></name><name><surname>Homann</surname><given-names>TM</given-names></name><name><surname>Silovitz</surname><given-names>D</given-names></name><name><surname>Spielvogel</surname><given-names>D</given-names></name><name><surname>Bodian</surname><given-names>CA</given-names></name><name><surname>Luehr</surname><given-names>M</given-names></name><etal/></person-group><article-title>Long-term survival after the Bentall procedure in 206 patients
with bicuspid aortic valve</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>84</volume><issue>4</issue><fpage>1186</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">17888968</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Konishi</surname><given-names>H</given-names></name><name><surname>Ohki</surname><given-names>S</given-names></name><name><surname>Saitoh</surname><given-names>T</given-names></name><name><surname>Kamisawa</surname><given-names>O</given-names></name><name><surname>Katoh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sinus of Valsalva dilatation after replacement of the ascending
aorta and aortic valve</article-title><source>Kyobu Geka</source><year>2003</year><volume>56</volume><issue>9</issue><fpage>786</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">12931591</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misawa</surname><given-names>Y</given-names></name><name><surname>Ohki</surname><given-names>S</given-names></name><name><surname>Sakano</surname><given-names>Y</given-names></name></person-group><article-title>Separate or composite graft replacement for diseases of both the
aortic valve and the ascending aorta</article-title><source>J Thorac Cardiovasc Surg</source><year>2005</year><volume>129</volume><issue>1</issue><fpage>236</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">15632860</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>KL</given-names></name><name><surname>Miller</surname><given-names>DC</given-names></name><name><surname>Fann</surname><given-names>JI</given-names></name><name><surname>Mitchell</surname><given-names>RS</given-names></name><name><surname>Robbins</surname><given-names>RC</given-names></name><name><surname>Moore</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Composite valve graft versus separate aortic valve and ascending
aortic replacement: is there still a role for the separate
procedure?</article-title><source>Circulation</source><year>1997</year><volume>96</volume><issue>9 Suppl</issue><fpage>368</fpage><lpage>375</lpage></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou&#x000eb;l</surname><given-names>R</given-names></name><name><surname>Soustelle</surname><given-names>C</given-names></name><name><surname>Kirsch</surname><given-names>M</given-names></name><name><surname>Hillion</surname><given-names>ML</given-names></name><name><surname>Renaut</surname><given-names>C</given-names></name><name><surname>Loisance</surname><given-names>DY</given-names></name></person-group><article-title>Long-term results of the Bentall operation versus separate
replacement of the ascending aorta and aortic valve</article-title><source>J Heart Valve Dis</source><year>2002</year><volume>11</volume><issue>4</issue><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">12150294</pub-id></element-citation></ref></ref-list></back></article>